Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of 4 weeks therapy with FK788 in subjects with chronic hepatitis C virus (HCV) infection. Also, to assess the effect of FK788 on serum ALT concentration and hepatitis C viral level during therapy and for four weeks following therapy.

Timeline

Start

2002-10

Primary completion

—

Completion

2006-03

Drugs

Indications